TIP in Patients Affected by Metastatic TNBC
Recruiting
- Conditions
- Metastatic Triple-negative Breast Cancer
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Fondazione per la Medicina Personalizzata
- Target Recruit Count
- 100
- Registration Number
- NCT05831553
- Locations
- 🇮🇹
Ospedale Santo Stefano, Prato, FI, Italy
🇮🇹IRCCS Istituto Europeo di Oncologia IEO, Milano, MI, Italy
🇮🇹Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, RM, Italy
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Phase 2
Active, not recruiting
- Conditions
- Other CancerBreast CancerGastrointestinal CancerNon Small Cell Lung Cancer
- Interventions
- Drug: Oncology DrugsDrug: Vismogedib
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Fondazione per la Medicina Personalizzata
- Target Recruit Count
- 400
- Registration Number
- NCT04591431
- Locations
- 🇮🇹
I.R.S.T. Srl Irccs, Meldola, Italy
🇮🇹Ospedale Classificato Sacro Cuore - Don Calabria, Negrar, Italy
🇮🇹I.R.C.C.S. Istituto Oncologico Veneto, Padova, Italy
© Copyright 2025. All Rights Reserved by MedPath